ATEC Alphatec Holdings, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
ATEC Stock | Fundamental Analysis & Investment Insights
NASDAQ
Healthcare
Medical Devices
Current Price
Live
$15.62
Analyst Target
$24.92
+59.6%
Upside
52W High
$23.29
52W Low
$8.81
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
68%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals significant concerns with a Piotroski F-Score of 4/9, indicating borderline financial health, and the absence of an Altman Z-Score prevents a full solvency assessment. Despite strong revenue growth of 30.4% and a bullish analyst recommendation (strong_buy), the company is unprofitable with a -21.29% profit margin and an alarming ROE of -540.41%. High valuation multiples, including a Price/Book of 200.26 and Forward P/E of 79.16, are not supported by current earnings or cash flow, while insider selling of $55.28M in the last six months signals strong bearish sentiment from management. Technical trend is bearish, and recent price performance shows a sharp 1-month decline of -24.8%, suggesting weakening momentum.
Key Strengths
Strong year-over-year revenue growth of 30.40% outpaces sector average of 23.74%
High gross margin of 69.23% indicates strong pricing power and cost control in core operations
Recent earnings surprises have been positive, with 3 out of last 4 quarters beating estimates and an average surprise of 136.19%
Analyst consensus is strong_buy with a high target price of $24.92, implying 59.6% upside
Current ratio of 1.99 suggests adequate short-term liquidity
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health with multiple red flags in profitability and leverage
Extremely high debt/equity ratio of 16.84, vastly exceeding sector average of 1.03, signaling severe financial risk
Negative ROE (-540.41%) and negative profit margin (-21.29%) reflect deep unprofitability and poor capital efficiency
Insiders have sold $55.28M in shares over the last 6 months with zero buy transactions, indicating strong bearish sentiment
Price/Book of 200.26 and Forward P/E of 79.16 suggest extreme overvaluation relative to book value and earnings
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ATEC against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning ATEC from our newsroom.
Newest → oldest
No matching news yet.